Skip to content
drillr.ai
Sign up

06821.HK

Asymchem Laboratories (Tianjin) Co., Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 133.80
+0.00%
Ask drillr

  • Aug 24, 2026, 10:29 UTC

    Asymchem Laboratories announced its first-half 2026 results: revenue of 3.607 billion yuan, up 13.13% year-on-year, and net profit attributable to shareholders of 520 million yuan, down 15.71% from 617 million yuan in the same period of 2025.

    Source:

  • Aug 7, 2026, 23:56 UTC

    Chinese innovative drug and CXO stocks rebounded strongly, with the CSI Innovative Drug Industry Index rising 28.04% since June 9, 2026, and several stocks hitting daily limits on August 7, 2026.

    Source:

  • Jul 30, 2026, 10:57 UTC

    Asiachem plans to inject 1.2397 billion yuan into its controlled subsidiary Asiachem BIO via a capital increase, raising its stake from 83% to 83.5%.

    Source:

  • Jul 16, 2026, 09:25 UTC

    Citigroup reduced its long-term holding of Asymchem (Tianjin) H-shares on July 10, with the stake dropping from 5.09% to 2.92%.